Emcure Pharmaceuticals Limited — Apixaban Exporter Profile
Indian Pharmaceutical Exporter · #9 for Apixaban · $3.0M export value · DGFT Verified
Emcure Pharmaceuticals Limited is the #9 Indian exporter of Apixaban with $3.0M in export value and 122 verified shipments. Emcure Pharmaceuticals Limited holds a 1.7% market share in Apixaban exports across 2 countries. The company exports 39 pharmaceutical products worth $147.8M across 19 therapeutic categories.
Emcure Pharmaceuticals Limited — Apixaban Export Profile: Buyers & Destinations
Where Does Emcure Pharmaceuticals Limited Export Apixaban?
Emcure Pharmaceuticals Limited exports Apixaban to 2 countries. The largest destination is CANADA accounting for 100.0% of Emcure Pharmaceuticals Limited's Apixaban shipments. These destinations reflect Emcure Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Apixaban from Emcure Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MARCAN PHARMACEUTICALS INC., | CANADA | $1.8M | 69 |
| MARCAN PHARMACEUTICALS INC. | CANADA | $629.0K | 29 |
| MARCAN PHARMACEUTICALS INC | CANADA | $355.1K | 18 |
| MARCANPHARMACEUTICALS INC | CANADA | $92.8K | 2 |
| MARCAN PHARMA | CANADA | $26 | 3 |
| MISOM LABS LTD | MALTA | $12 | 1 |
Emcure Pharmaceuticals Limited supplies Apixaban to 6 buyers globally. The largest buyer is MARCAN PHARMACEUTICALS INC., (CANADA), followed by MARCAN PHARMACEUTICALS INC. (CANADA) and MARCAN PHARMACEUTICALS INC (CANADA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Apixaban Export Value and How Much Does Emcure Pharmaceuticals Limited Contribute?
India exported $85.0M worth of Apixaban through 4,492 shipments from 171 suppliers to 98 countries, serving 371 buyers globally. Emcure Pharmaceuticals Limited contributes $3.0M to this total, accounting for 1.7% of India's Apixaban exports. Emcure Pharmaceuticals Limited ships Apixaban to 2 countries through 6 buyers.
What Is the Average Shipment Value for Emcure Pharmaceuticals Limited's Apixaban Exports?
Emcure Pharmaceuticals Limited's average Apixaban shipment value is $24.4K per consignment, based on 122 shipments totaling $3.0M. The largest destination is CANADA (100.0% of Emcure Pharmaceuticals Limited's Apixaban exports).
How Does Emcure Pharmaceuticals Limited Compare to Other Indian Apixaban Exporters?
Emcure Pharmaceuticals Limited ranks #9 among 171 Indian Apixaban exporters with a 1.7% market share. The top 3 exporters are INTAS PHARMACEUTICALS LIMITED ($18.7M), APOTEX RESEARCH PRIVATE LIMITED ($18.1M), SANDOZ PRIVATE LIMITED ($15.6M). Emcure Pharmaceuticals Limited processed 122 shipments to 2 destination countries.
What Apixaban Formulations Does Emcure Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| M-APIXABAN TABLET 2.5 MG 60T CA (PACK SI | $193.0K | 5 |
| M-APIXABAN TABLET 5 MG 180T CA (PACK SIZ | $126.9K | 4 |
| M-APIXABAN TABLET 5MG 180T CA (PACK SIZE | $86.2K | 2 |
| MAR-APIXABAN TABLETS 2.5 MG 500T CA | $53.5K | 2 |
| APIXABAN TABLETS 5 MG 500T CA-MAR (PACKSIZE 1X500T) BATCH NO:H240932A MFG:MAR-2024 EXP:FEB-2026 | $50.0K | 1 |
| APIXABAN TABLETS 5 MG 500T CA-MAR (PACKSIZE 1X500T) BATCH NO:H240931 MFG:MAR-2024 EXP:FEB-2026 | $50.0K | 1 |
| APIXABAN TABLETS 5 MG 180T CA-BIO (PACKSIZE 1X180T) BATCH NO:H240933C MFG APR-2024 EXP:MAR-2026 | $50.0K | 1 |
| APIXABAN TABLETS 5 MG 60T CA-BIO (PACK SIZE 1X60T) BATCH NO:H240932B MFG APR-2024 EXP:MAR-2026 | $50.0K | 1 |
| PHARMACEUTICALS PRODUCTS: RIVA-APIXABANTABS 5MG 500T CA BATCH NO: H250523C MFGDT: FEB-2025 EXP DT: JAN-2027 | $50.0K | 1 |
| M-APIXABAN TABLET 5 MG 180T CA BATCH NO | $47.7K | 1 |
Emcure Pharmaceuticals Limited exports 104 distinct Apixaban formulations including tablets, capsules, syrups, and combination drugs. The top formulation is M-APIXABAN TABLET 2.5 MG 60T CA (PACK SI with 5 shipments worth $193.0K.
Regulatory Requirements: Exporting Apixaban to Key Markets
What Emcure Pharmaceuticals Limited must comply with to export Apixaban to its top destination countries
Canada — HC
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Emcure Pharmaceuticals Limited Compare to Nearest Apixaban Exporters?
Exporters ranked immediately above and below #9 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | NATCO PHARMA LIMITED | $3.6M | 72 | 7 | $50.0K |
| 7 | MICRO LABS LIMITED | $3.4M | 68 | 14 | $50.0K |
| 9 | EMCURE PHARMACEUTICALS LIMITED ★ | $3.0M | 122 | 2 | $24.4K |
| 12 | SAVA HEALTHCARE LIMITED | $1.4M | 290 | 1 | $5.0K |
| 13 | TORRENT PHARMACEUTICALS LTD | $1.3M | 26 | 5 | $50.0K |
Emcure Pharmaceuticals Limited ranks #9 among 171 Indian Apixaban exporters. Average shipment value of $24.4K compared to the market average of $497.1K. The closest competitors by value are NATCO PHARMA LIMITED and MICRO LABS LIMITED.
Which Indian Ports Ship Apixaban Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 724 | 16.1% |
| SAHAR AIR CARGO ACC (INBOM4) | 674 | 15.0% |
| DELHI AIR CARGO ACC (INDEL4) | 607 | 13.5% |
| DELHI AIR | 364 | 8.1% |
| MUNDRA SEA | 146 | 3.3% |
| Bombay Air | 134 | 3.0% |
| JNPT/ NHAVA SHEVA SEA | 131 | 2.9% |
| AHEMDABAD AIR ACC (INAMD4) | 129 | 2.9% |
What Other Cardiovascular Products Does Emcure Pharmaceuticals Limited Export?
Emcure Pharmaceuticals Limited also exports these cardiovascular products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Emcure Pharmaceuticals Limited's Apixaban Exports
Emcure's extensive export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times for Indian exporters. This situation necessitates strategic adjustments in logistics and supply chain management to mitigate potential delays and cost escalations.
Conversely, the ongoing US-China trade tensions have opened opportunities for Indian pharmaceutical companies like Emcure to expand their footprint in the US market. The US's inclination to diversify its supply chain away from China presents a favorable environment for Indian exporters to increase their market share.
In the European Union, stringent regulatory changes, such as the Falsified Medicines Directive, impose additional compliance requirements on exporters. Emcure's adherence to these regulations is crucial for maintaining and expanding its presence in the EU market.
Emcure Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Emcure's export operations. The company has consistently met the Good Manufacturing Practice (GMP) requirements set by the FDA, WHO, and EU authorities. However, the evolving regulatory landscape demands continuous investment in quality assurance and compliance mechanisms to ensure uninterrupted market access.
Recent incidents, such as the brief shutdown of the Pune plant due to a fire, highlight the importance of robust risk management and compliance strategies to maintain operational continuity and regulatory adherence. (tipranks.com)
About Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited exports 39 products worth $147.8M. Beyond Apixaban, top products include Dolutegravir, Mycophenolate, Tenofovir, Iron, Melphalan. View the complete Emcure Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Apixaban — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Apixaban shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Emcure Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 122 individual customs records matching Emcure Pharmaceuticals Limited exporting Apixaban, covering 104 formulations to 2 countries via 6 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 98+ countries, 371+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Apixaban Export Data from Emcure Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Emcure Pharmaceuticals Limited's Apixaban exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Emcure Pharmaceuticals Limited
Full Company Profile →
39 products · $147.8M total trade · 19 categories
Apixaban Stats
Company Overview
Top Products by Emcure Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Emcure Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Apixaban. For current shipment-level data, contact TransData Nexus.